ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$ACAD:NASDAQ · ACADIA PHARMACEUTICALS INC

Sector: health

Conviction from: NASDAQ

52-week range: 15.8630.96

Acadia Pharmaceuticals is a biopharmaceutical company focused on central nervous system disorders and rare diseases, marketing Nuplazid for Parkinson's psychosis and Daybue for Rett syndrome.

3 tracked filer(s) hold this · 1 opened, 0 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s) · buyers (new/add) avg 61. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy105,337$2,122,5410.0%
Steve Cohen / Point7275Trimmed -53%1,164,383$23,462,3170.0%
Bridgewater55Trimmed -3%48,861$984,5490.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-02-26SCHEDULE 13D/ABAKER BROS. ADVISORS LP25.4%Highfiling

Trump & executive branch trades all Trump/exec trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-09-22Trump, Donald J PresidentSELL$15,001 - $50,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.